跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 54,590 条关于
“PD-1xLAG-3 bispecific antibody”
全部
54,590
临床试验
29,027
药物
7,562
机构
1,408
资讯
16,593
去年
China's Biopharma Sector Showcases Innovation Leadership at BIOSeedin 2025 Conference
2年前
Akeso's Bispecific Antibodies Show Promise in Lung and Colorectal Cancers
去年
Instil Bio and ImmuneOnco Advance PD-(L)1xVEGF Bispecific Antibody Clinical Development Strategy
8个月前
AbbVie Secures $5.6 Billion Licensing Deal for Novel PD-1/VEGF Bispecific Antibody RC148
去年
FS118, a LAG-3/PD-L1 Bispecific Antibody, Shows Modest Efficacy in Relapsed/Refractory DLBCL
2年前
Akeso Initiates Phase III Trial of Cadonilimab Bispecific Antibody for PD-L1 Negative NSCLC
去年
Instil Bio's PD-L1xVEGF Bispecific Antibody Shows Promise in NSCLC, Driving 48% Stock Surge
10个月前
Crescent Biopharma Advances PD-1 x VEGF Bispecific Antibody CR-001 Toward Phase 1 Trial
去年
Aptevo Advances APVO711: Novel Bispecific Antibody Combining PD-L1 Checkpoint Inhibition with CD40 Immune Activation
去年
Merck Expands Oncology Pipeline with $3.2B Deal for LaNova's Bispecific Antibody
第 1 页，共 1660 页
上一页
下一页
